News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
352,361 Results
Type
Article (21620)
Company Profile (110)
Press Release (330623)
Multimedia
Podcasts (133)
Webinars (20)
Section
Business (106178)
Career Advice (902)
Deals (18779)
Drug Delivery (129)
Drug Development (51238)
Employer Resources (80)
FDA (7933)
Job Trends (7867)
News (187508)
Policy (17503)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (755)
Accelerated approval (35)
ADA (26)
Adcomms (25)
Allergies (120)
Alliances (27974)
ALS (121)
Alzheimer's disease (890)
Antibody-drug conjugate (ADC) (323)
Approvals (8254)
Artificial intelligence (390)
ASCO (174)
Autoimmune disease (184)
Automation (27)
Bankruptcy (181)
Best Places to Work (5554)
BIO (37)
BIOSECURE Act (14)
Biosimilars (213)
Biotechnology (53)
Bladder cancer (91)
Brain cancer (46)
Breast cancer (335)
Cancer (3019)
Cardiovascular disease (309)
Career advice (759)
Career pathing (31)
CAR-T (140)
CDC (21)
Cell therapy (377)
Cervical cancer (22)
Clinical research (46051)
Collaboration (1326)
Commercialization (1)
Company closure (2)
Compensation (489)
Complete response letters (72)
COVID-19 (1177)
CRISPR (64)
C-suite (805)
Cystic fibrosis (95)
Data (4608)
Decentralized trials (3)
Denatured (30)
Depression (104)
Dermatology (54)
Diabetes (327)
Diagnostics (1981)
Digital health (25)
Diversity (9)
Diversity, equity & inclusion (22)
Drug discovery (257)
Drug pricing (220)
Drug shortages (36)
Duchenne muscular dystrophy (184)
Earnings (41974)
Editorial (56)
Employer branding (10)
Employer resources (80)
Events (52442)
Executive appointments (731)
FDA (9991)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (8)
Frontotemporal dementia (10)
Funding (866)
Gene editing (115)
Generative AI (46)
Gene therapy (336)
GLP-1 (937)
Government (2076)
Grass and pollen (4)
Guidances (219)
Healthcare (6017)
Hematology (92)
HIV (45)
Huntington's disease (34)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (86)
Immunology and inflammation (220)
Immuno-oncology (60)
Indications (147)
Infectious disease (1367)
Inflammatory bowel disease (150)
Inflation Reduction Act (12)
Influenza (61)
Intellectual property (173)
Interviews (123)
IPO (7456)
IRA (54)
Job creations (2448)
Job search strategy (657)
JPM (55)
Kidney cancer (15)
Labor market (83)
Layoffs (363)
Leadership (35)
Legal (4159)
Liver cancer (41)
Longevity (15)
Lung cancer (425)
Lymphoma (265)
Machine learning (25)
Management (31)
Manufacturing (754)
Marketing (2)
MASH (140)
Medical affairs (1)
Medical device (2020)
Medtech (2043)
Mergers & acquisitions (11974)
Metabolic disorders (1146)
mRNA (113)
Multiple sclerosis (127)
NASH (21)
Neurodegenerative disease (227)
Neuropsychiatric disorders (93)
Neuroscience (1860)
Neurotech (1)
NextGen: Class of 2026 (2368)
Non-profit (924)
Now hiring (61)
Obesity (660)
Opinion (251)
Ovarian cancer (102)
Pain (189)
Pancreatic cancer (142)
Parkinson's disease (226)
Partnered (20)
Patents (364)
Patient recruitment (412)
Peanut (22)
People (35139)
Pharmaceutical (55)
Pharmacy benefit managers (38)
Phase 1 (14545)
Phase 2 (19428)
Phase 3 (15588)
Pipeline (5460)
Policy (267)
Postmarket research (1624)
Preclinical (5085)
Press Release (29)
Prostate cancer (173)
Psychedelics (38)
Radiopharmaceuticals (223)
Rare diseases (747)
Real estate (3216)
Recruiting (35)
Regulatory (14499)
Reports (27)
Research institute (850)
Resumes & cover letters (142)
Rett syndrome (14)
RNA editing (18)
RSV (51)
Schizophrenia (149)
Series A (168)
Series B (107)
Service/supplier (6)
Sickle cell disease (82)
Special edition (25)
Spinal muscular atrophy (126)
Sponsored (20)
Startups (2061)
State (2)
Stomach cancer (13)
Supply chain (96)
Tariffs (97)
The Weekly (100)
Vaccines (481)
Venture capital (94)
Weight loss (468)
Women's health (68)
Worklife (10)
Date
Last 7 days (255)
Last 30 days (1031)
Last 365 days (15212)
2026 (8188)
2025 (15470)
2024 (17635)
2023 (19636)
2022 (25866)
2021 (26638)
2020 (24869)
2019 (20055)
2018 (15587)
2017 (17252)
2016 (16202)
2015 (18801)
2014 (14787)
2013 (12552)
2012 (13482)
2011 (13817)
2010 (12738)
Location
Africa (420)
Alabama (48)
Alaska (1)
Arizona (105)
Arkansas (9)
Asia (26470)
Australia (3417)
California (6016)
Canada (2223)
China (1037)
Colorado (249)
Connecticut (249)
Delaware (245)
Europe (54672)
Florida (1065)
Georgia (119)
Hawaii (2)
Idaho (20)
Illinois (587)
India (78)
Indiana (370)
Iowa (5)
Japan (463)
Kansas (92)
Kentucky (34)
Louisiana (11)
Maine (4)
Maryland (722)
Massachusetts (4804)
Michigan (77)
Minnesota (302)
Mississippi (3)
Missouri (49)
Montana (13)
Nebraska (15)
Nevada (41)
New Hampshire (11)
New Jersey (2316)
New Mexico (21)
New York (1652)
North Carolina (968)
North Dakota (2)
Northern California (2912)
Ohio (163)
Oklahoma (8)
Oregon (23)
Pennsylvania (1307)
Puerto Rico (28)
Rhode Island (29)
South America (617)
South Carolina (13)
South Dakota (1)
Southern California (2584)
Tennessee (86)
Texas (827)
United States (22639)
Utah (110)
Vermont (1)
Virginia (234)
Washington D.C. (60)
Washington State (474)
West Virginia (1)
Wisconsin (65)
Wyoming (1)
352,361 Results for "fennec pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - June 22, 2026
June 22, 2026
·
4 min read
Press Releases
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - June 15, 2026
June 15, 2026
·
4 min read
Press Releases
Fennec Announces Results of Annual Meeting - June 10, 2026
June 11, 2026
·
1 min read
Press Releases
Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
·
17 min read
Press Releases
Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026
May 7, 2026
·
2 min read
Press Releases
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
May 22, 2026
·
14 min read
Press Releases
Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting
April 22, 2026
·
11 min read
Press Releases
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 18, 2026
May 18, 2026
·
4 min read
Press Releases
Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
April 7, 2026
·
12 min read
Press Releases
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 31, 2026
March 31, 2026
·
4 min read
1 of 35,237
Next
